Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Medioni

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
The Journal of Urology|April 18, 2009
Response of renal cell carcinoma pancreatic metastasis to sunitinib treatment: a retrospective analysisJacques Medioni, Toni K Choueiri, Franck Zinzindohoué, et al.
Contemporary Clinical Trials|October 12, 2011
New criteria for analyzing the statistical relationships between biological parameters and therapeutic responses of xenografted tumor modelsJacques Medioni, Pascal Leuraud, Jean Yves Delattre, et al.
Cancer Investigation|April 8, 2011
Long-term response and postsurgical complete remissions after treatment with sunitinib malate, an oral multitargeted receptor tyrosine kinase inhibitor, in patients with metastatic renal cell carcinomaJorge Ayllon, Benoit Beuselinck, Alexandre Morel, et al.
Bulletin Du Cancer|May 31, 2012
[Renal carcinoma: point on treatment of brain metastasis]Corine Teghom, Philippe Giraud, Philippe Menei, et al.
Chest|January 18, 2002
Association between genetically determined pancreatic status and lung disease in adult cystic fibrosis patientsYann Loubières, Dominique Grenet, Brigitte Simon-Bouy, et al.
Expert Review of Anticancer Therapy|June 6, 2009
Everolimus (RAD001): an mTOR inhibitor for the treatment of metastatic renal cell carcinomaStéphane Oudard, Jacques Medioni, Jorge Aylllon, et al.
Urologic Oncology|November 17, 2009
Evolution of renal function in patients treated with antiangiogenics after nephrectomy for renal cell carcinomaVincent Launay-Vacher, Jorge Ayllon, Nicolas Janus, et al.
Palliative & Supportive Care|May 27, 2008
Screening for psychological distress in two French cancer centers: feasibility and performance of the adapted distress thermometerSylvie Dolbeault, Anne Bredart, Véronique Mignot, et al.
The Prostate|August 21, 2007
Serum PSA half-life as a predictor of survival for hormone-refractory prostate cancer patients: modelization using a standardized set of response criteriaEugeniu Banu, Adela Banu, Jacques Medioni, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 3, 2003
[Testicular metastasis of alveolar rhabdomyosarcoma: clinical case of a 19-year-old man]Jacques Medioni, Plinio Fernandez-Bruno, Véronique Meignin, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
The Journal of Urology|April 18, 2009
Response of renal cell carcinoma pancreatic metastasis to sunitinib treatment: a retrospective analysisJacques Medioni, Toni K Choueiri, Franck Zinzindohoué, et al.
Contemporary Clinical Trials|October 12, 2011
New criteria for analyzing the statistical relationships between biological parameters and therapeutic responses of xenografted tumor modelsJacques Medioni, Pascal Leuraud, Jean Yves Delattre, et al.
Cancer Investigation|April 8, 2011
Long-term response and postsurgical complete remissions after treatment with sunitinib malate, an oral multitargeted receptor tyrosine kinase inhibitor, in patients with metastatic renal cell carcinomaJorge Ayllon, Benoit Beuselinck, Alexandre Morel, et al.
Bulletin Du Cancer|May 31, 2012
[Renal carcinoma: point on treatment of brain metastasis]Corine Teghom, Philippe Giraud, Philippe Menei, et al.
Chest|January 18, 2002
Association between genetically determined pancreatic status and lung disease in adult cystic fibrosis patientsYann Loubières, Dominique Grenet, Brigitte Simon-Bouy, et al.
Expert Review of Anticancer Therapy|June 6, 2009
Everolimus (RAD001): an mTOR inhibitor for the treatment of metastatic renal cell carcinomaStéphane Oudard, Jacques Medioni, Jorge Aylllon, et al.
Urologic Oncology|November 17, 2009
Evolution of renal function in patients treated with antiangiogenics after nephrectomy for renal cell carcinomaVincent Launay-Vacher, Jorge Ayllon, Nicolas Janus, et al.
Palliative & Supportive Care|May 27, 2008
Screening for psychological distress in two French cancer centers: feasibility and performance of the adapted distress thermometerSylvie Dolbeault, Anne Bredart, Véronique Mignot, et al.
The Prostate|August 21, 2007
Serum PSA half-life as a predictor of survival for hormone-refractory prostate cancer patients: modelization using a standardized set of response criteriaEugeniu Banu, Adela Banu, Jacques Medioni, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 3, 2003
[Testicular metastasis of alveolar rhabdomyosarcoma: clinical case of a 19-year-old man]Jacques Medioni, Plinio Fernandez-Bruno, Véronique Meignin, et al.
Pageof 6